Phibro Animal Health's Zoetis MFA acquisition has created a larger animal health platform with stron

Phibro Animal Health (NASDAQ: PAHC) reported record fiscal 2026 sales and a sharp increase in adjust

Phibro Animal Health Corporation (PAHC) Q4 2026 Earnings Call Transcript

Phibro Animal Health NASDAQ: PAHC reported record fiscal 2026 sales and a sharp increase in adjusted

Phibro Animal Health (NASDAQ:PAHC) held its fourth-quarter earnings conference call on Thursday. Bel

Although the revenue and EPS for Phibro (PAHC) give a sense of how its business performed in the qua

Phibro Animal Health (PAHC) came out with quarterly earnings of $0.85 per share, beating the Zacks C

MFA SITE CLOSUREThrough the MFA acquisition in 2024, Phibro added several manufacturing facilities.

Phibro Animal Health (NASDAQ:PAHC) is looking for FY2027 Adj EPS of $3.41-$3.59 vs $3.34 analyst est

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Co

Besides Wall Street's top-and-bottom-line estimates for Phibro (PAHC), review projections for some o

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) expects to announce

Phibro Animal Health Corporation (NASDAQ: PAHC - Get Free Report) shares passed below its two hundre

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and

TEANECK, N.J.--(BUSINESS WIRE)--The Board of Directors of Phibro Animal Health Corporation (Nasdaq:

Investors interested in stocks from the Medical - Products sector have probably already heard of Phi

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t

Investors interested in stocks from the Medical - Products sector have probably already heard of Phi

Investors need to pay close attention to PAHC stock based on the movements in the options market lat

The average of price targets set by Wall Street analysts indicates a potential upside of 36.2% in Ph

https://www.sec.gov/ix?doc=/Archives/edgar/data/0001069899/000110465926078323/tm2619111d1_8k.htm

Investors interested in stocks from the Medical - Products sector have probably already heard of Phi

Phibro (PAHC) might move higher on growing optimism about its earnings prospects, which is reflected

This animal health provider, serving global livestock markets, reported a notable insider buy in its

Citigroup analyst Daniel Grosslight maintains Phibro Animal Health (NASDAQ:PAHC) with a Neutral a

FISCAL YEAR 2026 FINANCIAL GUIDANCEOur updated fiscal year 2026 financial guidance is as shown below

The Brazilian Ministry of Agriculture and Livestock (MAPA) published Ordinance No. 1617 on April 27,

Citigroup analyst Daniel Grosslight initiates coverage on Phibro Animal Health (NASDAQ:PAHC) with

Phibro Animal Health (NASDAQ:PAHC) raises FY2026 GAAP EPS guidance from $1.83-$2.08 to $2.08-$2.32 v

Phibro Animal Health (NASDAQ:PAHC) raises FY2026 Adj EPS guidance from $2.64-$2.81 to $2.93-$3.10 vs

Phibro Animal Health (NASDAQ:PAHC) reported quarterly earnings of $0.87 per share which beat the ana

JP Morgan analyst Ekaterina Knyazkova maintains Phibro Animal Health (NASDAQ:PAHC) with a Overwei

Phibro Animal Health (NASDAQ:PAHC) raises FY2026 Adj EPS guidance from $2.52-$2.70 to $2.64-$2.81 vs

Phibro Animal Health (NASDAQ:PAHC) reported quarterly earnings of $0.73 per share which beat the ana

 TEANECK, N.J.--(BUSINESS WIRE)-- Phibro Animal Health Corporation (NASDAQ:PAHC), a global leader in

B of A Securities analyst Derik De Bruin maintains Phibro Animal Health (NASDAQ:PAHC) with a Unde

U.S. stock futures were swinging on Thursday following Wednesday's advances. Futures of major be